Kentucky, US-headquartered contract research organisation (CRO) Pharmaceutical Product Development (PPD) has rolled out its microbiology testing services across its Belgium and Singapore facilities.
The expansion of the microbiology, peripheral blood mononuclear-cell and molecular-pathology services will enable the two international labs to test bacteriology, mycology, parasitology and microbioterrorism pathogens.
The Asian and European sites will be able to conduct virology testing, including real-time polymerase chain-reaction and viral-load tests, genotying and single nucleotide polymorphisms analyses.
In addition, both will now have the capabilities to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms.
“Adding these services to our Brussels and Singapore labs expands our ability to provide clients in Europe and Asia Pacific an important component of laboratory testing for infectious diseases,” said Elena Logan, senior vice president of central labs for PPD.
“PPD is unique in that we offer fully integrated clinical trial management and central laboratory services, enabling us to provide increased efficiencies, greater study flexibility and added value to our clients.”